Advertisements
Advertisements
Question
How did an American Company, Eli Lilly use the knowledge of r-DNA technology to produce human insulin?
Advertisements
Solution
The structure of insulin consists of two short polypeptide chains chain A and chain B, linked together by disulphide bridges. In mammals, including human beings, insulin is synthesised as a pro-hormone, which contains an extra stretch called the C peptide, which is removed during maturation into insulin. The rDNA technique is used for assembling insulin into the mature form.
In 1983, Eli Lilly, an American company, prepared two DNA sequences corresponding to the A and B chains of human insulin and introduced them into the plasmids of E. coli to produce insulin chains. Chains A and B were produced separately, extracted and combined by creating disulphide bonds to form human insulin.
APPEARS IN
RELATED QUESTIONS
Recombination DNA−technology is of great importance in the field of medicine. With the help of a flow chart, show how this technology has been used in preparing genetically engineered human insulins.
What is gene therapy? Illustrate using the example of adenosine deaminase (ADA) deficiency.
State the cause of ADA deficiency in humans.Mention a possible cure for an ADA deficiency patient.
Describe the steps that are followed during secondary treatment of sewage.
The first clinical gene therapy was done for the treatment of ________.
Vaccines that use components of a pathogenic organism rather than the whole organism are called ____________.
Mention the number of primers required in each cycle of PCR. Write the role of primers and DNA polymerase in PCR. Name the source organism of the DNA polymerase used in PCR.
How is the amplification of a gene sample of interest carried out using PCR?
What are recombinant vaccines? Explain the types.
A patient suffering from diabetes mellitus will have ______.
Which of the following is a neuropeptide hormone?
C-peptide of human insulin is ______.
Choose the correct option regarding retrovirus.
When gene targetting involving gene amplification is attempted in an individual’s tissue to treat disease, it is known as ______
With regard to insulin choose the correct options.
- C-peptide is not present in mature insulin.
- The insulin produced by rDNA technology has C-peptide.
- The pro-insulin has C-peptide.
- A-peptide and B-peptide of insulin are interconnected by disulphide bridges.
Choose the correct answer from the options given below.
Taking examples under each category, discuss upstream and downstream processing.
How is a mature, functional insulin hormone different from its prohormone form?
A cell-free method of amplifying DNA first developed in the mid 1980's revolutionised the field of biotechnology, Name the method and explain the basic steps of the technique involved.
Eli Lilly's contribution for diabetic patients through r-DNA technology has been overwhelmingly accepted. Explain how?
In humans, somatic gene therapy was carried out to correct an immunodeficiency disease. Name this disease.
